Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc.

PVCT
Provectus Biopharmaceuticals, Inc.US flagOther OTC
0.06
USD
+0.00
- -
25.01MMarket Cap

Income Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
4
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
4
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
21
14
13
17
25
25
13
8
6
5
5
3
3
5
5
+ Selling, General & Admin
12
9
9
11
13
16
5
3
2
2
2
2
2
3
4
+ Research & Development
9
5
4
6
11
8
8
5
4
3
3
2
2
2
2
+ Other Operating Expense
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-1
- -
Operating Income (Loss)
-21
-14
-13
-17
-25
-25
-13
-8
-6
-5
-5
-3
-3
-5
-5
- Non-Operating (Income) Loss
-2
-2
15
-7
- -
-1
- -
- -
1
2
1
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
1
1
2
1
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
1
1
2
1
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-2
-2
15
-7
- -
-1
- -
-1
-1
- -
- -
- -
- -
- -
- -
Pretax Income
-19
-13
-28
-10
-25
-24
-14
-8
-7
-7
-6
-4
-3
-5
-6
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-19
-13
-28
-10
-25
-24
-14
-8
-7
-7
-6
-4
-3
-5
-6
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-19
-13
-28
-10
-25
-24
-14
-8
-7
-7
-6
-4
-3
-5
-6
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-19
-13
-28
-10
-25
-24
-14
-8
-7
-7
-6
-4
-3
-5
-6
- Preferred Dividends
- -
- -
1
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-20
-13
-29
-10
-25
-27
-14
-8
-7
-7
-6
-4
-3
-5
-6
EBIT
-21
-14
-13
-17
-25
-25
-13
-8
-6
-5
-5
-3
-3
-5
-5
EBITDA
-21
-14
-12
-16
-24
-24
-13
-7
-6
-5
-5
-3
-3
-5
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-21
-14
-13
-17
-25
-25
-13
-8
-6
-5
-5
-3
-3
-5
-5
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
1
1
1
1
1
1
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
106
113
132
176
196
234
369
382
387
393
408
419
420
420
420
Basic EPS, GAAP
-0.19
-0.11
-0.22
-0.06
-0.13
-0.11
-0.04
-0.02
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
Basic EPS from Cont Ops
-0.18
-0.11
-0.21
-0.06
-0.13
-0.1
-0.04
-0.02
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
Diluted Weighted Avg Shares
106
113
132
176
196
234
369
382
387
393
408
419
420
420
420
Diluted EPS, GAAP
-0.19
-0.11
-0.22
-0.06
-0.13
-0.11
-0.04
-0.02
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
Diluted EPS from Cont Ops
-0.18
-0.11
-0.21
-0.06
-0.13
-0.1
-0.04
-0.02
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01

Balance Sheet (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
8
1
16
19
15
2
1
1
1
- -
3
2
1
1
1
+ Cash, Cash Equivalents & STI
8
1
16
17
14
1
- -
- -
1
- -
1
- -
- -
- -
- -
+ Cash & Cash Equivalents
8
1
16
17
14
1
- -
- -
1
- -
1
- -
- -
- -
- -
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
1
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
1
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
3
2
1
1
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
6
5
4
7
6
4
2
1
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
6
5
4
7
6
4
2
1
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
6
5
4
4
3
2
2
1
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
6
5
4
4
3
2
2
1
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
3
3
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
13
6
20
26
20
6
3
2
1
1
4
2
1
1
1
+ Payables & Accruals
- -
1
1
1
4
2
4
4
2
7
3
5
5
3
4
+ Accounts Payable
- -
- -
- -
- -
2
2
3
3
1
1
1
2
2
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
- -
2
- -
- -
1
1
6
2
2
3
2
3
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
24
2
2
3
3
3
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
1
24
2
2
3
3
3
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
2
1
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
1
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
1
1
1
4
2
4
4
3
31
8
8
9
7
7
+ LT Debt
- -
- -
- -
- -
- -
- -
9
14
20
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
9
14
20
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
3
1
13
- -
- -
- -
- -
1
3
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
3
1
13
- -
- -
- -
- -
1
3
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
3
1
13
- -
- -
- -
10
15
23
- -
- -
- -
- -
- -
- -
Total Liabilities
3
2
13
1
4
2
13
19
26
31
8
8
9
7
7
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
116
123
153
181
197
209
209
209
210
210
242
243
245
252
257
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
116
123
153
181
197
208
208
209
209
210
241
243
245
251
256
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-106
-118
-146
-156
-181
-205
-219
-227
-234
-240
-246
-250
-253
-257
-263
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
10
4
7
25
16
3
-10
-17
-24
-30
-4
-6
-8
-6
-6
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
10
4
7
25
16
3
-10
-17
-24
-30
-4
-6
-8
-6
-6
Total Liabilities & Equity
13
6
20
26
20
6
3
2
1
1
4
2
1
1
1
Shares Outstanding
111
118
160
185
205
365
371
385
390
399
419
419
420
420
420
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-8
-1
-16
-17
-14
-1
9
14
20
24
1
2
3
3
3
Net Debt to Equity
-76.91
-27.81
-236.79
-69.04
-86.9
-33.6
-93.33
-79.7
-82.27
-78.03
-24.25
-32.84
-37.88
-47.78
-41.25
Tangible Common Equity Ratio
57
-41.84
15.07
95.6
76.48
36.44
-621.05
-1,681.98
-1,945.89
-5,126.66
-119.8
-306.82
-525.67
-594.61
-905.78
Current Ratio
29.33
2.39
30.6
22.53
3.57
0.85
0.27
0.25
0.33
0.01
0.45
0.23
0.15
0.14
0.08
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-19
-13
-28
-10
-25
-24
-14
-8
-7
-7
-6
-4
-3
-5
-6
+ Depreciation & Amortization
1
1
1
1
1
1
1
1
1
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
3
- -
17
-4
2
4
- -
- -
- -
- -
- -
- -
- -
1
1
+ Stock-Based Compensation
3
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-1
- -
17
-4
2
4
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
-1
- -
- -
-1
4
-2
2
2
- -
2
4
- -
- -
- -
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
1
1
- -
1
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
-1
- -
- -
- -
3
-2
2
2
- -
2
2
1
1
1
1
+ Inc (Dec) in Other
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
2
-1
-1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-17
-11
-10
-14
-17
-22
-10
-5
-6
-4
-1
-3
-3
-3
-3
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
10
5
18
11
14
4
- -
- -
- -
- -
- -
- -
- -
- -
1
+ Increase in Capital Stock
10
5
18
11
14
4
- -
- -
- -
- -
- -
- -
- -
- -
1
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
4
19
9
6
3
3
1
2
2
2
+ Cash From Debt
- -
- -
- -
- -
- -
4
19
9
6
3
3
2
2
3
3
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
7
- -
6
4
1
2
-9
-4
- -
- -
1
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
17
5
24
16
14
9
9
5
7
4
4
1
2
3
3
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
-6
14
2
-3
-13
-1
- -
1
- -
3
-2
- -
-1
- -
EBITDA
-21
-14
-12
-16
-24
-24
-13
-7
-6
-5
-5
-3
-3
-5
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-17
-11
-10
-14
-17
-22
-10
-5
-6
-4
-1
-3
-3
-3
-3
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
-17
-11
-11
-14
-17
-21
8
4
- -
-1
2
-2
- -
-1
-1
Free Cash Flow per Basic Share
-0.16
-0.1
-0.07
-0.08
-0.09
-0.09
-0.03
-0.01
-0.02
-0.01
- -
-0.01
-0.01
-0.01
-0.01
Price/Free Cash Flow
-4.98
-5.62
-32.16
-10.16
-4.38
-0.21
-2.93
-3.67
-3.93
-5.58
-22.16
-14.94
-15.66
-15.35
-7.06
Cash Flow to Net Income
0.89
0.9
0.36
1.35
0.71
0.9
0.77
0.64
0.89
0.61
0.18
0.86
0.83
0.69
0.6
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -